IFNB1 and pancreatic adenocarcinoma: Therefore, in this study, we evaluated the anti-tumour activity of IFN-α and IFN-β in 11 human pancreatic adenocarcinoma cell lines and assessed the correlation between the responsiveness to type-I IFNs and the expression of IFNAR-1 and IFNAR-2c receptors.